Dexcom Announces Upcoming Conference Presentations
Get Alerts DXCM Hot Sheet
Join SI Premium – FREE
SAN DIEGO--(BUSINESS WIRE)-- DexCom, Inc. (NASDAQ: DXCM) today announced that Jereme Sylvain, Executive Vice President and Chief Financial Officer, will present an update on the company at the following upcoming investor conferences:
- BofA Securities 2022 Healthcare Conference on Wednesday, May 11, 2022 at 5:40pm (EST).
- William Blair 42nd Annual Growth Stock Conference on Wednesday, June 8, 2022 at 5:00pm (EST).
Links to the webcasts will be available on the Dexcom Investor Relations website at investors.dexcom.com and will be archived there for future reference.
About DexCom, Inc.
DexCom, Inc. empowers people to take control of diabetes through innovative continuous glucose monitoring (CGM) products. Headquartered in San Diego, California, Dexcom has emerged as a leader of diabetes care technology. By listening to the needs of patients, caregivers, and clinicians, Dexcom simplifies and improves diabetes management around the world.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220510005142/en/
DexCom, Inc.
Sean Christensen
Senior Director – Investor Relations and Corporate FP&A
[email protected]
(858) 200-0200
Source: DexCom, Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- AIS Healthcare Celebrates National Physicians Week
- Tikehau Capital: Disclosure of Shares Repurchases From 22 March 2024 to 28 March 2024
- Weekly Recap: 12 Press Releases You Might Have Missed
Create E-mail Alert Related Categories
Business Wire, Press ReleasesRelated Entities
William BlairSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!